MENU

XTLB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

XTL Biopharmaceuticals (XTLB) Ownership - Who owns XTL Biopharmaceuticals?

XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

5 Badner Street

Phone

+972 36116600

Employees

4

Web

https://www.xtlbio.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

6.59M

P/E Ratio

N/A

Total Cash

371K

Projected Growth

N/A

Total Debt

86K

Revenue

968K

Risk (Beta)

1.43

Dividend Yield

N/A

Total Cash/Share

0.15

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

XTLB

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for XTLB

A.I. Advisor

published General Information

General Information

a developer of therapeutics to treat hepatitis and other infectious diseases, using human antibodies and synthetic chemicals

Industry Biotechnology

Profile

Details

Industry

Biotechnology

Address

5 Badner Street

Phone

+972 36116600

Employees

4

Web

https://www.xtlbio.com